Implant-free MIGS
in Standalone
or Combo Cataract
OMNI enables a comprehensive glaucoma procedure that
targets three areas of resistance: Trabecular meshwork,
Schlemm's canal, and the collector channels.
OMNI
®
Surgical
System
INDICATIONS FOR USE: The OMNI
®
Surgical System is indicated for canaloplasty (microcatheterization
and transluminal viscodilation of Schlemm's canal) followed by trabeculotomy (cu ing of trabecular
meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma.
CONTRAINDICATIONS: Do not use the OMNI Surgical System in any situations where the iridocorneal
angle is compromised or has been damaged (e.g., from trauma or surgery), since it may not be possible
to visualize the angle or to properly pass the microcatheter. Do not use the OMNI Surgical System in
patients with angle recession; neovascular glaucoma; chronic angle closure; narrow-angle glaucoma;
traumatic or malignant glaucoma; or narrow inlet canals with plateau iris. Do not use the OMNI Surgical
System in quadrants with previous MIGS implants. Visit omnisurgical.com/ifu to access the instructions
for use, warnings, precautions, and adverse event information.
©2024 Sight Sciences. Sight Sciences, the Sight Sciences logo, and OMNI are registered trademarks of
Sight Sciences. 10/2024 OM-3300-US.v1
Explore more at
sightsciences.com/omni
